Theralase Technologies Inc. V.TLT

Projected Math

[99942Apophis]

Yes CancerSlayer I have tried various projections for best and worse case scenarios without hard numbers but solely relying on full optimized protocol should show 75-80% in the 25 required patients. With each passing day those hard numbers draw closer my opinion and expectations are because of the initial fumble (TLT) management will make absolutely sure everything is spelled out to perfection with a resounding touchdown.  In my opinion out of the full 100-125 patients a net total CR could possibly score 90+% and again that is my biased opinion.

[Rumpl3StiltSkin]

Yes Guys, And at some point some analyst is going to notice that the CR % is approaching high 80s or low 90s. By then TLT should have multiple irons in the fire too, IMO. No brainer where SP will go from there. 

[Pandora]

So all you 50 year olds can be quite optimistic :-))

[Rumpl3StiltSkin]

Pando this data will be coming in over the next year or so. Will probably lead to something big like a buyout or major partnership. Hang in there.

[menoalittle]

>> Will probably lead to something big like a buyout or major partnership. Hang in there I'm leaning towards Merck.

[gojotv!]

Nobody wants a buyout. We want sales, stock splits and re-splits, dividends for LIFE and.... The QuAAAAAAAAHN! If you don't want it, feel free to sell when your price hits. There'll be plenty of takers. GLTA!

[menoalittle]

me thinks Merck tends to be very conservative, so don't expect any offers from them anytime soon.  Better for them (and us) to pay much higher price after waitig until things here are much farther along, more proven, and the decimal point in the stock price has shifted at a notch or two.   And btw, Merck already pays a dividend. So, I'd vote in favor of a 1 for 1 equity